Search Results - "Willems, Henriette M. G"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1
  2. 2

    Systematic Investigation of the Permeability of Androgen Receptor PROTACs by Scott, Duncan E, Rooney, Timothy P. C, Bayle, Elliott D, Mirza, Tashfina, Willems, Henriette M. G, Clarke, Jonathan H, Andrews, Stephen P, Skidmore, John

    Published in ACS medicinal chemistry letters (13-08-2020)
    “…Bifunctional molecules known as PROTACs simultaneously bind an E3 ligase and a protein of interest to direct ubiquitination and clearance of that protein, and…”
    Get full text
    Journal Article
  3. 3
  4. 4

    The rational design of ARUK2007145, a dual inhibitor of the α and γ isoforms of the lipid kinase phosphatidylinositol 5-phosphate 4-kinase (PI5P4K) by Aldred, Gregory G, Rooney, Timothy P. C, Willems, Henriette M. G, Boffey, Helen K, Green, Christopher, Winpenny, David, Skidmore, John, Clarke, Jonathan H, Andrews, Stephen P

    Published in RSC medicinal chemistry (18-10-2023)
    “…The phosphatidylinositol 5-phosphate 4-kinases (PI5P4Ks) are therapeutic targets for diseases such as cancer, neurodegeneration and immunological disorders as…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Identification of ARUK2002821 as an isoform-selective PI5P4Kα inhibitor by Willems, Henriëtte M. G, Edwards, Simon, Boffey, Helen K, Chawner, Stephen J, Green, Christopher, Romero, Tamara, Winpenny, David, Skidmore, John, Clarke, Jonathan H, Andrews, Stephen P

    Published in RSC medicinal chemistry (25-05-2023)
    “…The phosphatidylinositol 5-phosphate 4-kinases (PI5P4Ks) play a central role in regulating cell signalling pathways and, as such, have become therapeutic…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Disease phenotypic screening in neuron-glia cocultures identifies blockers of inflammatory neurodegeneration by Birkle, Timothy J.Y., Willems, Henriette M.G., Skidmore, John, Brown, Guy C.

    Published in iScience (19-04-2024)
    “…Neuropathology is often mediated by interactions between neurons and glia that cannot be modeled by monocultures. However, cocultures are difficult to use and…”
    Get full text
    Journal Article
  11. 11

    Generation and Selection of Novel Estrogen Receptor Ligands Using the De Novo Structure-Based Design Tool, SkelGen by Firth-Clark, Stuart, Willems, Henriëtte M. G, Williams, Anthony, Harris, William

    “…A de novo design approach to generating novel estrogen receptor (ER) ligands is described. The SkelGen program was used to generate ligands in the active sites…”
    Get full text
    Journal Article
  12. 12

    De Novo Ligand Design to Partially Flexible Active Sites:  Application of the ReFlex Algorithm to Carboxypeptidase A, Acetylcholinesterase, and the Estrogen Receptor by Firth-Clark, Stuart, Kirton, Stewart B, Willems, Henriëtte M. G, Williams, Anthony

    “…Reflex is a recent algorithm in the de novo ligand design software, SkelGen, that allows the flexibility of amino acid side chains in a protein to be taken…”
    Get full text
    Journal Article
  13. 13

    Receptor Flexibility in the in Silico Screening of Reagents in the S1‘ Pocket of Human Collagenase by Källblad, Per, Todorov, Nikolay P, Willems, Henriëtte M. G, Alberts, Ian L

    Published in Journal of medicinal chemistry (20-05-2004)
    “…A major difficulty in structure-based molecular design is the prediction of the structure of the protein−ligand complex because of the enormous number of…”
    Get full text
    Journal Article
  14. 14
  15. 15

    SynthFormer: Equivariant Pharmacophore-based Generation of Molecules for Ligand-Based Drug Design by Jocys, Zygimantas, Willems, Henriette M. G, Farrahi, Katayoun

    Published 03-10-2024
    “…Drug discovery is a complex and resource-intensive process, with significant time and cost investments required to bring new medicines to patients. Recent…”
    Get full text
    Journal Article